Cutaneous and visceral loxoscelism: A systematic review;Loxoscelismo cutáneo y cutáneo-visceral: Revisión sistemática

Revista Chilena de Infectologia

Volumn 26, Issue 5, 2009, Pages 420-432

  Manríquez M , Juan J ^a   Silva V , Sergio ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Evidence based medicine; Loxoscelism; Systematic review

Indexed keywords

CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HUMAN; REVIEW; SKIN DISEASE; SPIDER BITE;

ARACHNIDISM; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; SKIN DISEASES;

EID: 70350707713     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Ríos J, Pérez M, Sánchez M, Bettini M, Mieres J, Paris E. Caracterización clínicoepidemiológica telefónica de la mordedura por araña de rincón, en un centro de información toxicológica de Chile, durante el año 2005. Rev Méd Chile 2007; 135: 1160-5.
2. Swanson D L, Vetter R S. Loxoscelism. Clin Dermatol 2006; 24: 213-21.
3. Gertsch W J, Ennik F. The spider genus Loxosceles in North America, Central America and the West Indies (Araneae loxoscelidae). Bull Am Mus Nat Hist 1983; 175: 264-360.
4. Van Den Berg C W, De Andrade R M, Magnoli F C, Marchbank K J, Tambourgi D V. Loxosceles spider venom induces metalloproteinase mediated cleavage of MCP/CD46 and MHCI and induces protection against C-mediated lysis. Immunology 2002; 107: 102-10.
5. Futrell J M. Loxoscelism. Am J Med Sci 1992; 304: 261-7.
6. Southcott R V. Spiders of the genus Loxosceles in Australia. Med J Aust 1976; 1: 406-8.
7. Saraco S, De Roodt A. Envenenamiento por animales ponzoñosos. Loxoscelismo. ATA 2005; 67: 45-9.
8. Da Silva P, Bertoni R, Appel M, Mangili O, Gremsky W, Sanches S. Brown spider and loxoscelism. Toxicon 2004; 44: 693-709.
9. Young A R, Pincus S J. Comparison of enzymatic activity from three species of necrotizing arachnids in Australia: Loxosceles rufescens, Badumna insignis and Lampona cylindrata. Toxicon 2000; 39: 391-400.
10. Foradori M J, Smith S C, Smith E, Wells R E. Survey for potentially necrotizing spider venoms, with special emphasis on Cheiracanthium mildei. Comp Biochem Physiol C Toxicol Pharmacol 2005; 141: 32-9.
11. Bodner M R, Callahan M, Binford GJ. Evolutionary origin and loss of sphingomyelinase D in the Sicarius and Loxosceles lineages. 29th Annual Meeting of Amer Arachnol Soc. Akron OH, 29 Jun 2005.
12. Schenone H. Cuadros tóxicos producidos por mordeduras de araña en Chile: latrodectismo y loxoscelismo. Rev Méd Chile 2003; 131: 437-44.
13. Tambourgi D, Paixao-Cavalcante D, Goncalves R, Fernándes-Pedrosa M F, Morgan P, Van De Berg C. Loxosceles sphingomyelinase induces complement- dependent dermonecrosis, neutrophil infiltration, and endogenous gelatinase expression. J Invest Dermatol 2005; 124: 725-31.
14. Schenone H. Cutaneous loxoscelism with edematous predominance. Bol Chil Parasitol 1998; 53 (3-4): 78-83.
15. Hogan C, Barbaro K, Winkel K. Loxoscelism: Old obstacles, new directions. Ann Emerg Med 2004; 44: 608-24.
16. Swanson D, Vetter D. Bites of brown recluse spiders and suspected necrotic arachnidism, N Engl J Med 2005; 325: 700-7.
17. Manríquez J J, Silva S. Dermatología basada en la evidencia: importancia y conceptos generales. Piel 2006; 21 (3): 118-23.
18. Manríquez J J, Silva S. Dermatología basada en evidencia: revisiones sistemáticas y meta-análisis. Piel 2006 21 (7): 323-8.
19. Manríquez J.J., Silva S. Dermatología basada en la evidencia: ¿un enfoque posible? Revista Medicina Cutánea Iberoamericana 2006; 34 (5): 187-97.
20. Letelier L M, Manríquez J J, Rada G. Systematic reviews and meta-analysis: are the best evidence? Rev Med Chile 2005; 133 (2): 246-9.
21. Manríquez J J. A highly sensitive search strategy for clinical trials in Literatura Latino Americana e do Caribe em Ciências da Saúde (LILACS) was developed. J Clin Epidemiol 2008; 61(4): 407-11.
22. Manríquez J J, Villouta F, Williams H. Evidence based dermatology: Number needed to treat and it relation to others risk measures. J Am Acad Dermatol 2007; 56 (4): 664-71.
23. National Health and Medical Research Council. Disponible en http://www.nhmrc.gov.au (accedido 1/12/2007).
24. Cochrane Reviewer Handbook. Disponible en http://www.cochrane.org/resources/handbook/. (accedido el 1/12/2007)
25. Von Elm E, Altman D G, Egger M, Pocock S J, Gotzsche P C, Vandenbroucke J P; for the STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008; 61 (4): 344-9.
26. En: Insuficiencia renal aguda por Loxoscelismo: estudio de 14 casos presentados en el Hospital Cayetano Heredia (Kemper Vásquez RS, ed). s.l: UPCH. Facultad de Medicina Alberto Hurtado, 1987.
27. En: Loxoscelismo en niños: estudio retrospectivo de pacientes hospitalizados entre 1970 y 1990 en los Servicios de Pediatría del Hospital Cayetano Heredia e Instituto Nacional de Salud del Niño (Mangiante Russo RMI, ed). s.l: UPCH. Facultad de Medicina Alberto Hurtado, 1991.
28. En: Loxoscelismo en adultos morbi - mortalidad y factores asociados al desarrollo de la forma viscero - hemolítica (Quispe Avendaño AJ, ed). Arequipa: s.n, 1997.
29. En: Loxoscelismo no estado do Paraná: análise epidemiológica dos acidentes causados por Loxosceles Heinecken & Lowe, 1832, no período de 1993 a 2000 (Silva EMd, ed). Rio de Janeiro: s.n, 2002.
30. Anderson P C. Loxoscelism threatening pregnancy: Five cases. Am J Obstet Gynecol 1991; 165: 1454-6.
31. Arias Obarrio H J. Loxoscelismo cutáneonecrótico simple (a propósito de cinco observaciones). Arch Argent Dermatol 1982; 32: 223-32.
32. Arnold R E. Brown recluse spider bites: five cases with a review of the literature. JACEP 1976; 5: 262-4.
33. Barretto OCdO, Cardoso J L, Cillo Dd. Viscerocutaneous form of loxoscelism and erythrocyte glucose-6-phosphate deficiency. Rev Inst Med Trop Säo Paulo 1985; 27: 264-7.
34. Barrio A, Ibarra-Grasso A. Cases of severe loxoscelism which took place in Buenos Aires and its surroundings in the last years. Mem Inst Butantan 1966; 33: 809-19.
35. Benavides M I, Moncada X. The treatment of cutaneous loxoscelism with dapsone. Rev Med Chil 1990; 118: 1247-50.
36. Bravo M. Study of anti-loxosceles serum action on hemolytic and ulcero-necrotic cutaneous effects of Loxosceles laeta venom. Rev Med Chil 1994; 122: 625-9.
37. Braz A. Development and evaluation of the neutralizing capacity of horse antivenom against the Brazilian spider Loxosceles intermedia. Toxicon 1999; 37: 1323-8.
38. Burton K G. Nitroglycerine patches for brown recluse spider bites. Am Fam Physician 1995; 51: 1401.
39. Cacy J, Mold J W. The clinical characteristics of brown recluse spider bites treated by family physicians: an OKPRN Study. Oklahoma Physicians Research Network. J Fam Pract 1999; 48: 536-42.
40. Cardoso J L. Loxoscelismo: estudo de 242 casos (1980-1984). Rev Soc Bras Toxicol 1988; 1: 58-60.
41. Cermeño J, Carpio N, Salazar N. Aracnoidismo en el Hospital Universitario Ruíz Páez estado Bolívar Venezuela: y revisión de la literatura. Rev Soc Venez Microbiol 2004; 24: 95-7.
42. Clowers T D. Wound assessment of the Loxosceles reclusa spider bite. J Emerg Nurs 1996; 22: 283-7.
43. Cohen N. Dermonecrotic loxoscelism in the Mediterranean region. J Toxicol-Cutaneous Ocular Toxicol 1999; 18: 75-83.
44. Dasilva M V. Utilization of exchange-transfusion procedure in serious human loxoscelism. Rev Institut Med Tropical S Paulo 1988; 30: 259-63.
45. Dyachenko P, Ziv M, Rozenman D. Epidemiological and clinical manifestations of patients hospitalized with brown recluse spider bite. J Eur Acad Dermatol Venereol 2006; 20: 1121-5.
46. Elbahlawan L M, Stidham G L, Bugnitz M C, Storgion S A. Quasney MW. Severe systemic reaction to Loxosceles reclusa spider bites in a pediatric population. Pediatr Emerg Care 2005; 21 (3): 177-80.
47. Ersek R A. Treatment of spider bites with silverimpregnated porcine xenografts. Tex Med 1985; 81: 32-5.
48. FOS Barbaro K C, Fan H W. A clinical and epidemiological study of Loxosceles spider envenoming in Santa Catarina, Brazil. Trans R Soc Trop Med Hyg 1998; 92 (5): 546-8.
49. Farace F, Lissia M, Mele A, Masia D R, Rubino C. Local cutaneous arachnidism: A report of three cases and their management. J Plastic, Reconstructive Aesthetic Surg 2006; 59 (2): 197-201.
50. Felix R. Mordedura de araña loxosceles: en pacientes pediátricos. Rev Serv Sanid Fuerzas Polic 1987; 48: 43-6.
51. Fishman T D. Wound assessment and evaluation. Brown recluse spider bite. Dermatol Nurs 1999; 11: 290-1.
52. González C. Acute renal failure in viscerocutaneous loxoscelism: 11 cases. Rev Med Chil 1986; 114: 1155-9.
53. Gutiérrez Puelma J, Sagua Franco H. Loxoscelism in children. Analysis of 15 cases. Rev Chil Pediatr 1979; 50: 21-7.
54. Hailey D. Hyperbaric oxygen therapy - recent findings on evidence for its effectiveness. Update (Structured abstract). 2003.
55. Iribarren O. Loxoscelism in the province of Valdivia (X Region, Chile). Clinical study of 9 cases. Bol Chil Parasitol 1987; 42: 68-71.
56. King L E Jr, Rees R S. Dapsone treatment of a brown recluse bite. JAMA 1983; 250: 648.
57. Leach J, Bassichis B, Itani K. Brown recluse spider bites to the head: Three cases and a review. Ear, Nose and Throat J 2004; 83(7): 465-70.
58. Lee M S, Bernstein H H. Immunizations, neonatal jaundice, and animal-induced injuries. Curr Opin Pediatr 2005: 418-29.
59. Malaque C M. Clinical and epidemiological features of definitive and presumed loxoscelism in Sao Paulo, Brazil. Rev Inst Med Trop Sao Paulo 2002; 44: 139-43.
60. Marques-da-Silva E. Loxosceles spider bites in the state of Paraná, Brazil: 1993-2000. J Venom Anim Toxins Incl Trop Dis 2006; 12: 110-23.
61. Martino O A. Emponzonamiento humano provocado por venenos de origen animal. Estudio epidemiologico clinico y experimental. Arch Argent Dermatol 1981; 31: 41-7.
62. Maya Rodríguez L E. Hemodialysis with artificial kidney in the treatment of acute renal insufficiency from loxoscelism. An Fac Med Lima 1964; 47: 419-39.
63. McClure D N. Necrotising arachnidism treated with hyperbaric oxygen. Med J Aust 1995; 163: 51-2.
64. Medical Services Advisory C. Hyperbaric oxygen therapy (Structured abstract), 2001.
65. Osborn C D. Treatment of venomous bite by high voltage direct current. J Okla State Med Assoc 1990; 83: 9-14.
66. Ramires E N. Evaluation of the efficacy of vacuum cleaners for the integrated control of brown spider Loxosceles intermedia. J Venom Anim Toxins Incl Trop Dis 2007; 13: 607-19.
67. Sams H H. Nineteen documented cases of Loxosceles reclusa envenomation. J Am Acad Dermatol 2001; 44: 603-8.
68. Schenone H. Loxoscelismo en pediatría: Región Metropolitana Chile. Rev Chil Pediatr 2001; 72: 100-9.
69. Schenone H. Latrodectism and loxoscelism incidence in Chile, clinical characteristics, diagnosis, treatment and prevention. Mem Inst Butantan 1966; 33: 207-11.
70. Schenone H. Cutaneous loxoscelism with edematous predominance. Bol Chil Parasitol 1998; 53: 78-83.
71. Schenone H, Prats F. Arachnidism by Loxosceles laeta. Report of 40 cases of necrotic arachnidism. Arch Dermatol 1961; 83: 139-42.
72. Schenone H. Epidemiology and clinical course of loxoscelism. A study of 133 cases caused by the bite of the corner spider (Loxosceles laeta). Bol Chil Parasitol 1975; 30: 6-17.
73. Schenone H. Loxoscelism in Chile - epidemiological, clinical and experimental studies. Rev Instit Med Trop Sao Paulo 1989; 31: 403-15.
74. Skinner M W, Butler C S. Necrotising arachnidism treated with hyperbaric oxygen. Med J Austr 1995; 162: 372-3.
75. Soto L. Tres casos pediátricos de loxoscelismo cutáneo en zona rural de Valdivia: Chile. Bol Chil Parasitol 1991; 46: 74-6.
76. Valverde López J. Aspectos clínicos y epidemiológicos del loxoscelismo, Hospital Regional Docente de Trujillo, enero 2001 a noviembre 2003. Folia Dermatol Perú 2003; 14: 15-9.
77. Villanueva E. Hyperbaric oxygen therapy (Structured abstract). 2000.
78. Wright S W. Clinical presentation and outcome of brown recluse spider bite. Ann Emerg Med 1997; 30: 28-32.
79. Zavaleta Alfaro R L, Alvarado Ganoza G. Loxoscelismo en niños: algunos aspectos clínicos y epidemiológicos en el Hospital Belén de Trujillo. Diagnóstico (Perú) 1987; 20: 84-6.
80. Svendsen F J. Treatment of clinically diagnosed brown recluse spider bites with hyperbaric oxygen: a clinical observation. J Ark Med Soc 1986. 83: 199-204.
81. Maguiña Vargas C P. Uso de azúcar granulada en úlcera cutánea moderada a severa por loxoscelismo. Folia Dermatol Perú 2004; 15: 87-93.
82. Escalante Galindo P. Loxoscelismo local dermonecrótico en niños mordidos por la araña Loxosceles reclusa (araña "violinista"). Gac Méd Méx 1999; 135: 423-6.
83. Maguiña Vargas C. La dapsona (DDS) en el loxoscelismo cutáneo. Diagnóstico (Perú) 1987; 20: 58-64.
84. Schenone H. Estudio de 27 casos de loxoscelismo. Bol Chil Parasitol 1959; 14: 7-13.
85. Osborn C D. Treatment of spider bites by high voltage direct current. J Okla State Med Assoc 1991; 84: 257-60.
86. Maynor M L, Abt J L, Osborne P D. Brown recluse spider bites: beneficial effects of hyperbaric oxygen, J Hyperb Med 1992; 7: 89-102.
87. Auer A I, Hershey F B. Proceedings: Surgery for necrotic bites of the brown spider. Arch Surg 1974; 108: 612-8.
88. Mold J W, Thompson D M. Management of brown recluse spider bites in primary care. J Am Board Fam Pract 2004; 17: 347-52.
89. Rees R. The diagnosis and treatment of brown recluse spider bites. Ann Emerg Med 1987: 945-9.
90. Maguiña Vargas C, Gotuzzo Herencia E, Álvarez H. Nuevos esquemas terapéuticos en loxoscelismo cutáneo en Lima, Perú. Folia Dermatol Perú 1997; 8: 23-30.
91. Rees R S. Brown recluse spider bites. A comparison of early surgical excision versus dapsone and delayed surgical excision. Ann Surg 1985: 659-63.
92. Schulz K F, Chalmers I, Hayes R J. Empirical evidence of bias. J Am Med Acad 1995; 273: 408-12.
93. Iserson K V. Methemoglobinemia from dapsone therapy for a suspected brown spider bite. J Emerg Med 1985; 3: 285-8.
94. Pfeiffer C, Wozel G. Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol 2003; 48: 308-9.